2,630
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Novel risk prediction models, involving coagulation, thromboelastography, stress response, and immune function indicators, for deep vein thrombosis after radical resection of cervical cancer and ovarian cancer

, , , , , & show all
Article: 2204162 | Received 09 Feb 2023, Accepted 13 Apr 2023, Published online: 24 Apr 2023

References

  • Basaran, D., et al., 2021. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecologic Oncology, 163 (1), 36–40.
  • Bhandari, M., et al., 2022. Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy. Frontiers in Pharmacology, 13, 1035769.
  • Cires-Drouet, R.S., et al., 2022. Prevalence and clinical outcomes of hospitalized patients with upper extremity deep vein thrombosis. Journal of Vascular Surgery. Venous and Lymphatic Disorders, 10 (1), 102–110.
  • Collins, G.S., et al., 2015. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ (Clinical Research ed.), 350, g7594.
  • Collaborative; GlobalSurg Collaborative, C., 2022. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia, 77 (1), 28–39.
  • D’Oria, O., et al., 2022. The role of preoperative frailty assessment in patients affected by gynecological cancer: a narrative review. Italian Journal of Gynaecology and Obstetrics, 34 (02), 76–83.
  • Deitcher, S.R., 2003. Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies. Semin Thromb Hemost, 29, 247–258.
  • Donmez, T., et al., 2016. Is there any effect of pneumoperitoneum pressure on coagulation and fibrinolysis during laparoscopic cholecystectomy? PeerJ., 4, e2375.
  • Giannini, A., et al., 2020. Predictors of postoperative overall and severe complications after surgical treatment for endometrial cancer: the role of the fragility index. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 148 (2), 174–180.
  • James, L.M. and Georgopoulos, A.P., 2023. Immunogenetic profiles and associations of breast, cervical, ovarian, and uterine cancers. Cancer Informatics, 22, 11769351221148588.
  • Li, S., et al., 2020. Effects of choline supplementation on liver biology, gut microbiota, and inflammation in Helicobacter pylori-infected mice. Life Sciences, 259, 118200.
  • Line, B.R., 2001. Pathophysiology and diagnosis of deep venous thrombosis. Seminars in Nuclear Medicine, 31 (2), 90–101.
  • Loffredo, L., et al., 2022. Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications. Journal of Thrombosis and Haemostasis, 20, 72.
  • Mahasa, K.J., et al., 2022. A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept. Mathematical Biosciences and Engineering, 19 (5), 4429–4457.
  • Ogoh, S., et al., 2020. Arterial and venous cerebral blood flow responses to long-term head-down bed rest in male volunteers. Experimental Physiology, 105 (1), 44–52.
  • Othman, M. and Kaur, H., 2017. Thromboelastography (TEG). Methods in Molecular Biology, 1646, 533–543.
  • Peng, M., et al., 2021. Solid tumor complicated with venous thromboembolism: a 10-year retrospective cross-sectional study. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 27, 1076029620975484.
  • Saenger, J., et al., 2004. Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction. Journal of Cancer Research and Clinical Oncology, 130 (4), 203–210.
  • Sharma, A., et al., 2016. Effect of various pneumoperitoneum pressures on femoral vein hemodynamics during laparoscopic cholecystectomy. Updates in Surgery, 68 (2), 163–169.
  • Sone, K., et al., 2022. Transiently elevated D-dimer levels post-concentrated ascites reinfusion therapy cannot be used to predict deep vein thrombosis-pulmonary embolism. The Journal of Obstetrics and Gynaecology Research, 48 (3), 817–823.
  • Sturlese, E., et al., 2017. Thromboembolism prophylaxis in laparoscopic surgery for gynecologic benign diseases. Results of a single center experience in 922 procedures. Ann Ital Chir, 88, 342–347.
  • Sun, Y., et al., 2021. The low expression of long non-coding RNA Linc00638 contributes to rheumatoid arthritis progression by regulating inflammation and oxidative stress. Nan Fang Yi Ke Da Xue Xue Bao, 41 (7), 965–971.
  • Tian, Q. and Li, M., 2021. Risk factors of deep vein thrombosis of lower extremity in patients undergone gynecological laparoscopic surgery: what should we care. BMC Womens Health, 21, 130.
  • Wang, Z., et al., 2021. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer. Gynecologic Oncology, 163 (2), 358–363.
  • Yasui, M., et al., 2022. Risk factors for postoperative proximal deep vein thrombosis and pulmonary embolism after laparoscopic colorectal cancer surgery: analysis of a multicenter randomized controlled trial. Surgery Today, 52 (6), 881–888.
  • Yu, F.T., et al., 2011. A local increase in red blood cell aggregation can trigger deep vein thrombosis: evidence based on quantitative cellular ultrasound imaging. Journal of Thrombosis and Haemostasis, 9 (3), 481–488.
  • Yu, R., et al., 2020. Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery. Medicine, 99 (25), e20928.
  • Zhao, H., et al., 2022. Prevalence and treatment of venous thromboembolism in patients with solid tumors. Experimental and Therapeutic Medicine, 24 (6), 743.